The inhibitors of nucleotide biosynthesis leflunomide, FK778, and mycophenolic acid activate hepatitis b virus replication In Vitro
Hepatology, 03/19/2012HoppeSeyler K et al. –
The data indicate that – in contrast to their reported inhibitory effects on other viruses – both leflunomide and FK778 can augment HBV replication. Treatment with leflunomide, FK778, or mycophenolic acid (MPA) may bear the risk to enhance HBV replication in infected patients.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.